14x Revenue (average.metric for ASX listed pharma) or 45x Ebitda ..as per April 2023 EurozHart report..
go to Botanix website, under invest ..analyst coverage...
at usd 100mln sales , Mr. Market on average should value us at usd 1.4bln....but with our growth rates..like Japan 67% yoy and pipeline of super promising product we can be assured of Very conservatively usd2 bln valuation..
BOT - Anything but charting, page-6714
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.015(4.84%) |
Mkt cap ! $507.9M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.5¢ | 30.5¢ | $1.644M | 5.201M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 297837 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 356105 | 13 |
View Market Depth
| Last trade - 14.34pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
32.8¢ |
Change
0.015 ( 5.92 %) |
||||
| Open | High | Low | Volume | ||
| 31.0¢ | 32.8¢ | 30.8¢ | 3101422 | ||
| Last updated 14.50pm 14/06/2024 ? | |||||
| BOT (ASX) Chart |